Ovarian Cancer Recurrent Clinical Trials in Jerusalem
2 recruitingJerusalem, Israel
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Ovarian Cancer Recurrent
Merck Sharp & Dohme LLC460 enrolled23 locationsNCT06843447
Recruiting
Phase 1Phase 2
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer
Ovarian CancerOvarian Cancer Recurrent
Compugen Ltd60 enrolled28 locationsNCT06888921